 |
| Hussein Haidari, M.D., presents his research at the NeauxCancer Conference in New Orleans. |
“It’s a profound honor and privilege to represent USA Health at the esteemed CAGLA conference,” he said. “It’s an inspiring platform to showcase our dedication to clinical excellence, innovative research, and the compassionate care that defines our institution.”
Haidari presented a case involving the progression of esophageal lichen planus – a chronic inflammatory disease affecting skin and mucosa – to squamous cell carcinoma. The conclusion was that lichen planus, a very rare, but aggressive condition, is a risk factor for squamous cell carcinoma of the esophagus, as well as increases the risk for recurrent disease. As such, it underscores the need for close surveillance in patients with persistent or worsening symptoms.
Haidari completed medical school at Hawler Medical University in Erbil, Iraq. He sees patients at University Hospital and Stanton Road Clinic.
The CAGLA conference attracts medical oncologists, cancer surgeons, radiation oncologists, and other physicians, as well as advanced practice providers, medical trainees, nurses, pharmacists, and other healthcare professionals.
The three-day event covers wide-ranging topics beyond discussions about disease and emerging therapies, novel surgical approaches, precision medicine, and more, including health advocacy and policy.
CAGLA is a grassroots advocacy group that champions improved cancer care. Community leaders, dedicated physicians and resilient survivors unite to drive progress in healthcare policy and practice.